NCT07243327 ESWT vs Conventional Physical Therapy in Greater Trochanteric Pain Syndrome
| NCT ID | NCT07243327 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kanuni Sultan Suleyman Training and Research Hospital |
| Condition | Greater Trochanteric Pain Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2026-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-12-01 with a primary completion date of 2026-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare the effectiveness of Extracorporeal Shockwave Therapy (ESWT) with conventional physical therapy in patients with Greater Trochanteric Pain Syndrome (GTPS). GTPS is a common cause of lateral hip pain, often related to gluteal tendinopathy rather than trochanteric bursitis. Sixty patients will be randomly assigned to two groups: ESWT or conventional physical therapy (TENS, hot pack, ultrasound). Pain (VAS), hip function (Harris Hip Score), lower limb function (LEFS), and global improvement will be evaluated at baseline, week 3, and week 12. The purpose of this study is to determine which treatment provides greater pain relief and functional improvement.
Eligibility Criteria
Inclusion Criteria: * Age between 18 and 65 years * Lateral hip pain for at least 3 months * Ability to understand study procedures and provide informed consent Exclusion Criteria: * Hip deformities * Gluteus medius, gluteus minimus, or piriformis tendon tears * Lumbar radiculopathy or history of lumbar spine surgery * Recent trauma or active infection in the hip region * Corticosteroid injection to the hip within the last 6 months * Neurological, psychiatric, or rheumatologic diseases * Active malignancy or systemic inflammatory disease * Cognitive impairment preventing cooperation
Contact & Investigator
Zeynep Karakuzu Güngör
PRINCIPAL INVESTIGATOR
Kanuni Sultan Suleyman Training and Research Hospital
Frequently Asked Questions
Who can join the NCT07243327 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Greater Trochanteric Pain Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07243327 currently recruiting?
Yes, NCT07243327 is actively recruiting participants. Contact the research team at zeynepkarakuzu@hotmail.com.tr for enrollment information.
Where is the NCT07243327 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07243327 clinical trial?
NCT07243327 is sponsored by Kanuni Sultan Suleyman Training and Research Hospital. The principal investigator is Zeynep Karakuzu Güngör at Kanuni Sultan Suleyman Training and Research Hospital. The trial plans to enroll 60 participants.